iCAD, Inc. (NASDAQ: ICAD) is a global leader on a mission to create a world where cancer can't hide by providing clinically proven AI-powered solutions that enable medical providers to accurately and ...
CHICAGO--(BUSINESS WIRE)--Today GE HealthCare (Nasdaq: GEHC) announced the release of a new, all-in-one platform of artificial intelligence (AI) apps to support clinicians with breast cancer detection ...
ICAD Inc ICAD is poised to benefit in the long term from its AI-driven cancer detection tools and electronic brachytherapy product, according to BTIG. The iCAD Analyst: Marie Thibault initiated ...
Groundbreaking ProFound AI Risk Helps Transform Breast Cancer Screening from an Age-Based Paradigm to Risk-Adapted Precision Screening, Individualized for Each Woman NASHUA, N.H., Nov. 30, 2020 (GLOBE ...
Icad Inc ICAD shares are trading higher Monday after the company announced a strategic development and commercialization agreement with Alphabet Inc's GOOG Google Health. The agreement will allow ...
NASHUA, N.H.--(BUSINESS WIRE)-- iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment ...
World’s first and largest open AI Marketplace expands access to ProFound AI for U.S. radiologists, 80 percent of whom use Nuance’s radiology reporting system NASHUA, N.H., Dec. 04, 2019 (GLOBE ...
(MENAFN- GlobeNewsWire - Nasdaq) NASHUA, N.H., July 08, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the“Company”), a global leader in clinically proven AI-powered cancer detection ...
NASHUA, N.H., April 08, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) ("iCAD" or the "Company") a global leader on a mission to create a world where cancer can’t hide by providing clinically ...
iCAD to Present at the Spring Into Action - Best Ideas Virtual Investor Conference on May 17th, 2022
NASHUA, NH / ACCESSWIRE / May 12, 2022 /iCAD, Inc. (NASDAQ:ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the Company will ...
iCAD, Inc. (NASDAQ: ICAD) is a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered solutions that enable medical providers to accurately and ...
Company implements corporate strategic realignment Partnership-based recurring revenue model anticipated to drive future growth Cost structure reduction to decrease expenses by over $3 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results